Learn More about Lumida ETF
Powered by LumidaWealth.com
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
No Result
View All Result
  • Lumida Wealth
  • Lumida Ledger
  • LUMIDA ETF
  • About Us
Home Themes AI

AI-Driven Drug Firm METiS Eyes $200 Million Hong Kong IPO Amid Growing Biotech Momentum

by Team Lumida
May 12, 2025
in AI
Reading Time: 4 mins read
A A
0
AI Investment Boom: How Tech Giants Are Leading the Charge

"Machine Learning & Artificial Intelligence" by mikemacmarketing is licensed under CC BY 2.0

Share on TelegramShare on TwitterShare on FacebookShare on LinkedinShare on Whatsapp

Key Takeaways:

Powered by lumidawealth.com

  • METiS Pharmaceuticals, an AI-driven drug discovery and delivery firm, is considering a Hong Kong IPO to raise up to $200 million by the end of 2025.
  • The company has raised $300 million in funding since its inception in 2020, with notable backers like CICC Capital, China Taiping Insurance, and HongShan (formerly Sequoia China).
  • METiS operates globally, with offices in Hangzhou, Beijing, Shanghai, and Cambridge, Massachusetts.
  • The IPO reflects growing investor interest in AI-powered biotech solutions, despite ongoing market uncertainties.

What Happened?

METiS Pharmaceuticals, a Hangzhou-based AI-driven drug discovery and delivery company, is reportedly planning an initial public offering (IPO) in Hong Kong to raise as much as $200 million. The company is working with advisers to finalize the IPO, which could take place before the end of 2025. While details such as the size and timing of the offering are still under discussion, METiS has not commented on the matter.

Since its founding in 2020, METiS has raised $300 million in funding, including a $100 million Series C round in June 2023 led by CICC Capital and supported by China Taiping Insurance and HongShan. The company has a global presence, with offices in China and the US.


Why It Matters?

METiS’s potential IPO highlights the growing intersection of artificial intelligence and biotechnology, a sector that has attracted significant investor interest due to its potential to revolutionize drug discovery and delivery. The $200 million IPO would provide METiS with additional capital to expand its operations and accelerate its AI-driven drug development initiatives.

The move also underscores Hong Kong’s appeal as a hub for biotech IPOs, particularly for Chinese firms seeking to tap into global capital markets. Despite broader market uncertainties, the biotech sector remains resilient, with investors drawn to its long-term growth potential.


What’s Next?

If METiS proceeds with the IPO, investors should monitor the company’s valuation, financial performance, and pipeline of AI-driven drug solutions. The success of the IPO could set a precedent for other AI-focused biotech firms considering public listings.

Additionally, the broader market environment, including geopolitical tensions and regulatory developments in Hong Kong, will play a critical role in shaping the outcome of this offering. Investors should also watch for updates on METiS’s partnerships and advancements in its drug discovery platform.

Source
Previous Post

US-China Tariff Reductions Signal Temporary Trade Truce, Markets React Positively

Next Post

Citi Predicts Stablecoins Will Expand Beyond Crypto, Reaching $1.6 Trillion by 2030

Recommended For You

Anthropic Wins Partial Victory in AI Copyright Case, Setting Precedent for Future Rulings

by Team Lumida
11 hours ago
Anthropic Wins Partial Victory in AI Copyright Case, Setting Precedent for Future Rulings

Key Takeaways: Powered by lumidawealth.com A federal judge ruled that Anthropic’s use of purchased books to train its AI models is legal under U.S. copyright law, likening it to...

Read more

Amazon to Invest$54 Billion in U.K. to Boost Innovation and AI Development

by Team Lumida
2 days ago
Amazon’s $100 Billion Bet: AI Over Retail

Key Takeaways: Powered by lumidawealth.com Amazon plans to invest $54 billion* (£40 billion) in the U.K. over the next three years to support innovation and the country’s AI initiatives....

Read more

Senate Retains AI Regulation Ban in Trump’s Tax Bill, Benefiting Big Tech

by Team Lumida
3 days ago
China’s AI Startups Challenge Global Leaders Amid U.S. Trade Curbs

Key Takeaways: Powered by lumidawealth.com A Republican-backed provision to block U.S. states from enforcing new AI regulations remains in President Trump’s tax and spending package. The provision would deny...

Read more

Apple Explores Potential Acquisition of AI Startup Perplexity Amid Growing Competition

by Team Lumida
5 days ago
Perplexity AI Ventures into Ad Space: What Investors Need to Know

Key Takeaways: Powered by lumidawealth.com Apple executives are discussing a potential bid for Perplexity AI, valued at $14 billion*, to enhance its AI capabilities. The acquisition could address the...

Read more

SoftBank Proposes $1 Trillion AI and Robotics Hub in Arizona, Seeks TSMC and Trump Administration Support

by Team Lumida
6 days ago
SoftBank Proposes $1 Trillion AI and Robotics Hub in Arizona, Seeks TSMC and Trump Administration Support

Key Takeaways: Powered by lumidawealth.com SoftBank founder Masayoshi Son plans to build a $1 trillion industrial complex in Arizona, codenamed "Project Crystal Land," focused on AI and robotics manufacturing....

Read more

Salesforce Strategist Warns of AI Era Risks, Highlights$1 Billion AI Investment Strategy

by Team Lumida
6 days ago
Salesforce Q2 FY25 Earnings Highlights: Strong Growth Led by Integrating AI Solutions

Key Takeaways: Powered by lumidawealth.com Salesforce’s Chief Futures Officer, Peter Schwartz, emphasizes the need for reinvention in the AI era, warning that rapid technological change could put even industry...

Read more

OpenAI Introduces Flexible Credit-Based Pricing for ChatGPT Enterprise

by Team Lumida
6 days ago
OpenAI Hack: Why AI Companies Are Prime Targets for Cyberattacks

Key Takeaways: Powered by lumidawealth.com OpenAI has shifted its ChatGPT Enterprise pricing model to a credit-based system, allowing businesses to customize features and tools based on their needs. The...

Read more

Meta Offers OpenAI Staff$100 Million Bonuses to Build AI Team, Says Sam Altman

by Team Lumida
1 week ago
Meta Offers OpenAI Staff$100 Million Bonuses to Build AI Team, Says Sam Altman

Key Takeaways: Powered by lumidawealth.com Meta Platforms is offering OpenAI employees signing bonuses of up to$100 million and lucrative annual compensation packages to recruit top AI talent. Meta CEO...

Read more

Amazon CEO Andy Jassy Says AI Will Reduce Workforce Over Time

by Team Lumida
1 week ago
Amazon’s $100 Billion Bet: AI Over Retail

Key Takeaways: Powered by lumidawealth.com Amazon plans to reduce its workforce in the coming years as generative AI and automation eliminate the need for certain roles. CEO Andy Jassy...

Read more

Pope Leo XIV Makes AI Regulation a Key Focus of His Papacy

by Team Lumida
1 week ago
Pope Leo XIV Makes AI Regulation a Key Focus of His Papacy

Key Takeaways: Powered by lumidawealth.com Pope Leo XIV, the first American pope, has declared artificial intelligence (AI) a central issue of his papacy, likening its societal impact to the...

Read more
Next Post
Bitcoin Plunges to $64K Amid U.S. Tech Stock Turmoil

Citi Predicts Stablecoins Will Expand Beyond Crypto, Reaching $1.6 Trillion by 2030

Can Apple’s Vision Pro Bounce Back with a Budget-Friendly Model?

Apple Weighs iPhone Price Hikes Amid Trade Risks and Supply Chain Shifts

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related News

GM’s Chevy Trax Faces Tariff Challenges Amid Trade War, Threatening Affordable SUV Market

GM’s Chevy Trax Faces Tariff Challenges Amid Trade War, Threatening Affordable SUV Market

April 16, 2025
a piece of rock sitting on top of a table

North American Uranium Market Stalls Amid Tariff Uncertainty and Utility Hesitation

March 31, 2025
Ultra-Rich Families Fuel $20 Billion Surge in Private Equity Buyouts

Ultra-Rich Families Fuel $20 Billion Surge in Private Equity Buyouts

June 7, 2024

Subscribe to Lumida Ledger

Browse by Category

  • Lifestyle
    • Family Office
    • Health and Longevity
    • Next Gen Wealth
    • Trust, Tax, and Estate
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Latest
    • Macro
    • Markets
    • Real Estate
  • Research
    • Trackers
  • Themes
    • Aging & Longevity
    • AI
    • Biotech
    • CRE
    • Cybersecurity
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
    • Software
Facebook Twitter Instagram Youtube TikTok LinkedIn
Lumida News

Premium insights to help you invest beyond the ordinary. Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser

CATEGORIES

  • Aging & Longevity
  • AI
  • Alt Assets
  • Biotech
  • CRE
  • Crypto
  • Cybersecurity
  • Digital Assets
  • Equities
  • Family Office
  • Health and Longevity
  • Latest
  • Legacy Brands
  • Lifestyle
  • Macro
  • Markets
  • News
  • Next Gen Wealth
  • Nuclear Renaissance
  • Private Credit
  • Real Estate
  • Software
  • Themes
  • Trackers
  • Trust, Tax, and Estate

BROWSE BY TAG

AI AI chips AI demand Amazon Apple Artificial Intelligence Banking Bitcoin China Commercial Real Estate CPI Crypto Donald Trump EARNINGS ELON MUSK ETF Ethereum Federal Reserve financial services generative AI Goldman Sachs Google India Inflation Interest Rates Investment Strategy Japan Jerome Powell JPMorgan Markets Meta Microsoft Nasdaq Nvidia OpenAI private equity S&P 500 SEC Semiconductor stock market Tech Stocks tesla Trump Wells Fargo Whale Watch

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018

No Result
View All Result
  • Home
  • Earnings
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018